Editor's Note :

Editor's Note :

On Monday, we expect orders from the June 22 Conference at 9:30 a.m. and the final opinions of the term at 10 a.m.
Our first interim Stat Pack for October Term 2016, prepared by Kedar Bhatia, is available at this link.
The Supreme Court proceedings and orders in the legal challenges to the administration’s entry ban are available at this link.

Mylan Pharmaceuticals Inc. v. Apotex Inc.

Petition for certiorari denied on November 9, 2015
Docket No. Op. Below Argument Opinion Vote Author Term
15-307 Fed. Cir. N/A N/A N/A N/A OT 2015

Issue: (1) Whether Article III’s case or controversy requirement can be satisfied when the suit seeks a judgment of non-infringement of a disclaimed patent; and (2) whether Congress can create Article III jurisdiction by imposing statutory consequences that turn on obtaining a judgment of non-infringement of a disclaimed patent.

DateProceedings and Orders
Sep 8 2015Petition for a writ of certiorari filed. (Response due October 13, 2015)
Oct 5 2015Brief of respondent Apotex Inc. in opposition filed. VIDED.
Oct 20 2015Reply of petitioner Mylan Pharmaceuticals Inc. filed.
Oct 21 2015DISTRIBUTED for Conference of November 6, 2015.
Nov 9 2015Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
 
Share:
Term Snapshot
Awards